HSPB1 and TPI1 were selected for IHC validation in ccRCC tissues, with the staining pattern concordant with the proteomic analysis results; however, the authors missed the opportunity to further assess the expression of these proteins in other RCC lesions. This evidence concerns the gene HSPB1 and nonpapillary renal cell carcinoma.